Every 3 seconds another person gets Dementia

More than 200 experimental drugs have failed in clinical trials.

50% of dementia sufferers are undiagnosed and many are misdiagnosed

By 2050, 152 million people around the world will have Dementia

Dementia - A Global Healthcare Crisis

Oxford Brain Diagnostics' breakthrough technology aims to change the way Dementia is assessed.

Our technology Cortical Disarray Measurement seeks to bring hope to patients, clinicians and pharmaceutical companies by offering greater certainty in Alzheimer's disease diagnosis at the earliest opportunity.

We are committed to providing early diagnosis, disease prediction and progression tracking as clinical services. Our innovative technology strives to deliver products globally to patients.

Oxford Brain Diagnostics Ltd is a company registered in England and Wales. Registered No. 11703979 

Oxford Centre for Innovation, New Road, Oxford, OX1 1BY

VAT No. 321 3026 62